Wed, December 6, 2017
Tue, December 5, 2017
Mon, December 4, 2017
Fri, December 1, 2017
Thu, November 30, 2017
Wed, November 29, 2017
Tue, November 28, 2017
Mon, November 27, 2017
Wed, November 22, 2017
Tue, November 21, 2017
Mon, November 20, 2017
Fri, November 17, 2017
Thu, November 16, 2017
Wed, November 15, 2017
Tue, November 14, 2017
Mon, November 13, 2017
Fri, November 10, 2017
Thu, November 9, 2017

Tazeen Ahmad Maintained (ASND) at Strong Buy with Decreased Target to $43 on, Nov 17th, 2017


//stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-43-on-nov-17th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Tazeen Ahmad of B of A Securities, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Decreased Target from $46 to $43 on, Nov 17th, 2017.

Tazeen has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Tazeen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tazeen


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $50 on, Friday, September 22nd, 2017

Publication Contributing Sources